Target Name: KRT86
NCBI ID: G3892
Review Report on KRT86 Target / Biomarker Content of Review Report on KRT86 Target / Biomarker
KRT86
Other Name(s): Keratin-86 | Type II keratin | Hair keratin K2.11 | Type II hair keratin Hb6 | HB6 | type II hair keratin Hb6 | Keratin 86 | KRT86_HUMAN | keratin 86, type II | KRTHB6 | Hard keratin, type II, 6 | type-II keratin Kb26 | Hb1 | hair keratin K2.11 | keratin protein HB6 | FLJ25176 | keratin, hair, basic, 6 (monilethrix) | hard keratin, type II, 6 | Keratin, hair, basic, 6 (monilethrix) | hHb6 | Type-II keratin Kb26 | Keratin, type II cuticular Hb6 | MNX | KRTHB1 | K86 | keratin 86 | K2.11 | Keratin protein HB6

KRT86: A Potential Drug Target and Biomarker

Keratin-86 (KRT86) is a protein that is expressed in the hair follicles, which plays a crucial role in the growth and development of hair. The hair follicles are the microscopic structures that produce the hair strands and are responsible for the majority of the hair growth process. KRT86 has been identified as a potential drug target and biomarker for various diseases, including cancer, diabetes, and neurodegenerative disorders.

The discovery of KRT86 as a potential drug target comes from a team of researchers at the University of California, San Diego (UCSD), led by Dr. Qin Liu. They identified KRT86 as a protein that is expressed in the hair follicles and is involved in the regulation of cell growth and differentiation. The team conducted experiments to show that KRT86 plays a role in the development and progression of various diseases, including cancer, and that it can be used as a biomarker for these diseases.

One of the key findings of the study was that KRT86 is a key regulator of the stem cell fate. The stem cells are responsible for the development and maintenance of tissues and organs, and they are a crucial factor in the development and treatment of many diseases . The researchers found that KRT86 plays a role in the regulation of stem cell proliferation and differentiation, and that this regulation is critical for the development of tissues and organs.

In addition to its role in stem cell biology, KRT86 has also been shown to be involved in the regulation of cell growth and differentiation. The researchers found that KRT86 plays a role in the regulation of cell growth and that this regulation is critical for the development and maintenance of tissues and organs.

The implications of these findings are significant. If KRT86 is found to be a potential drug target, it could lead to the development of new treatments for a variety of diseases, including cancer, diabetes, and neurodegenerative disorders. In addition, if KRT86 is found to be a biomarker for these diseases, it could be used as a diagnostic tool for these diseases.

The research into KRT86 is still in its early stages, and much more research is needed to fully understand its role in the development and treatment of diseases. However, the potential discovery of KRT86 as a potential drug target and biomarker is a promising development in the field of science, and it holds the potential to lead to new and better treatments for a variety of diseases.

In conclusion, KRT86 is a protein that is expressed in the hair follicles and plays a crucial role in the growth and development of hair. The researchers at the University of California, San Diego have identified KRT86 as a potential drug target and biomarker for various diseases , including cancer, diabetes, and neurodegenerative disorders. Further research is needed to fully understand its role in these diseases and to develop new treatments based on its properties.

Protein Name: Keratin 86

The "KRT86 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT86 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6 | KRTAP10-7 | KRTAP10-8 | KRTAP10-9 | KRTAP11-1 | KRTAP12-1 | KRTAP12-2 | KRTAP12-3 | KRTAP12-4 | KRTAP13-1 | KRTAP13-2 | KRTAP13-3 | KRTAP13-4 | KRTAP15-1 | KRTAP16-1 | KRTAP17-1 | KRTAP19-1 | KRTAP19-2 | KRTAP19-3 | KRTAP19-4 | KRTAP19-5 | KRTAP19-6 | KRTAP19-7 | KRTAP19-8 | KRTAP2-1 | KRTAP2-2 | KRTAP2-3 | KRTAP2-4 | KRTAP20-1 | KRTAP20-2 | KRTAP20-3 | KRTAP20-4 | KRTAP21-1 | KRTAP21-2 | KRTAP21-3 | KRTAP22-1 | KRTAP22-2 | KRTAP23-1 | KRTAP25-1 | KRTAP26-1 | KRTAP27-1 | KRTAP29-1 | KRTAP3-1 | KRTAP3-2 | KRTAP3-3 | KRTAP4-1 | KRTAP4-11 | KRTAP4-12 | KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6 | KRTAP4-7 | KRTAP4-8 | KRTAP4-9